Andrew Dudum, CEO of Hims & Hers Health, Inc., executed multiple transactions between June 13 and June 16, 2025. On June 13, he exercised options to acquire 164,368 shares but also sold 90,672 shares on the same day. On June 16, further options were exercised to acquire an additional 125,335 shares, followed by sales totaling 158,762 shares, including those held in trust. These transactions might indicate that the CEO perceives the company's stock price to be nearing a peak, potentially causing market fluctuations, and investors should closely monitor the situation.